Delayed Graft FunctionGraft SurvivalKidney TransplantationGraft RejectionSurvival RateGraft Occlusion, VascularTissue DonorsLiver TransplantationTreatment OutcomeCadaverImmunosuppressive AgentsCold IschemiaTime FactorsOrgan PreservationLiving DonorsRetrospective StudiesSurvival AnalysisTransplantsCell SurvivalPrimary Graft DysfunctionPancreas TransplantationPostoperative ComplicationsFollow-Up StudiesKaplan-Meier EstimateTissue and Organ ProcurementTacrolimusIslets of Langerhans TransplantationBrain DeathBlood Vessel ProsthesisPrognosisTransplantation, HomologousCreatinineCyclosporineMycophenolic AcidKidneyWarm IschemiaDisease-Free SurvivalKidney Failure, ChronicOrgan Preservation SolutionsPolytetrafluoroethyleneTissue and Organ HarvestingDeathProportional Hazards ModelsRisk FactorsVascular PatencyReoperationImmunosuppressionSurvivalDonor SelectionLiver FailureAntilymphocyte SerumProspective StudiesMultivariate AnalysisPostoperative PeriodRenal DialysisBiopsyRaffinoseKidney Function TestsAnastomosis, SurgicalHeart TransplantationBlood Vessel Prosthesis ImplantationSaphenous VeinImmunohistochemistryLung TransplantationHistocompatibility TestingPolyethylene TerephthalatesAzathioprineGlomerular Filtration RateReperfusion InjuryIschemiaVeinsCohort StudiesNeoplasm StagingTransplantation, HeterotopicKidney DiseasesNephrectomyAge FactorsRisk AssessmentPredictive Value of TestsTumor Markers, BiologicalTransplantation, AutologousKidney Tubular Necrosis, AcuteIncidenceAcute DiseaseRegistriesRecurrenceTransplantation ImmunologyRats, Inbred LewChi-Square DistributionTransplantation, IsogeneicArteriovenous Shunt, SurgicalCoronary Artery BypassTreatment FailureBiological MarkersPrednisoneActuarial AnalysisTransplantation ToleranceRenal InsufficiencyGraft vs Host DiseaseDrug Therapy, Combination